Leerink Swann & Company is a full-service investment banking firm that provides institutional sales, healthcare equity research, corporate finance, and asset management services for high-net-worth clients. Leerink Swann & Company was voted Best Firm in both Biotechnology and Pharmaceuticals/Specialty Pharmaceuticals in the December 2001 Institutional Investor poll ranking the best boutique and regional firms by sector. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. MEDACorp is comprised of more than 3,000 consultants who are practicing physicians, surgeons, and biomedical professionals representing 55 clinical care specialties and 22 basic science disciplines.